Literature DB >> 18266311

Metastases and multiple myeloma generate distinct transcriptional footprints in osteocytes in vivo.

S Eisenberger1, K Ackermann, G Voggenreiter, H Sültmann, C Kasperk, W Pyerin.   

Abstract

Osteocytes are the most abundant bone cells, playing important roles in tissue maintenance. Little is known of how they react in vivo to cancer stress. Here we present a comparative study of the effect of a bone-residing tumour (myeloma) and metastases of bone-remote cancers on osteocytes. While no differences in morphology of the bone are seen, the changes in the transcriptome of osteocytes are specifically related to the tumour stress present. Screening approximately 22 000 genes in osteocytes prepared from cryosections of native bone using laser-supported microdissection, we observed approximately 1400 and approximately 1800 gene expression differences between osteocytes dissected from normal bone compared with those associated with metastases and multiple myeloma, respectively. The genes up-regulated due to the stress exerted by metastases were repressed by multiple myeloma and vice versa, indicating stress-specific footprints in the transcriptome of osteocytes. Functionally, the stressors seem to impose selective pressures on signalling pathways such as that of TGFbeta, a major player in bone biology. Our data show for the first time that the transcriptome of osteocytes in vivo becomes strongly affected by cancer stress, generating gene expression footprints which, in contrast to comparable morphological changes, appear to relate to the nature of cancer and might thus become helpful in distinguishing different bone diseases. Copyright (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266311     DOI: 10.1002/path.2322

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

Review 1.  Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.

Authors:  G Shay; L Hazlehurst; C C Lynch
Journal:  J Mol Med (Berl)       Date:  2015-10-01       Impact factor: 4.599

Review 2.  Pathways Controlling Formation and Maintenance of the Osteocyte Dendrite Network.

Authors:  Jialiang S Wang; Marc N Wein
Journal:  Curr Osteoporos Rep       Date:  2022-09-10       Impact factor: 5.163

Review 3.  Contributions of the host microenvironment to cancer-induced bone disease.

Authors:  Sam W Z Olechnowicz; Claire M Edwards
Journal:  Cancer Res       Date:  2014-03-05       Impact factor: 12.701

Review 4.  Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy.

Authors:  Denise Toscani; Marina Bolzoni; Marzia Ferretti; Carla Palumbo; Nicola Giuliani
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

Review 5.  The Role of Sclerostin in Bone Diseases.

Authors:  Elias S Vasiliadis; Dimitrios-Stergios Evangelopoulos; Angelos Kaspiris; Ioannis S Benetos; Christos Vlachos; Spyros G Pneumaticos
Journal:  J Clin Med       Date:  2022-02-02       Impact factor: 4.241

Review 6.  Role of osteocytes in multiple myeloma bone disease.

Authors:  Jesus Delgado-Calle; Teresita Bellido; G David Roodman
Journal:  Curr Opin Support Palliat Care       Date:  2014-12       Impact factor: 2.302

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.